Notícias e actividades

Saúde - Gabinete do Secretário de Estado da Saúde

Atualização de dados pessoais diretamente através da área reservada do Portal SNS 24.

Saúde - Gabinete da Ministra

Atribuição de louvor.

SPMS - Serviços Partilhados do Ministério da Saúde, E. P. E.

Aquisição de serviços de desenvolvimento e apoio técnico ao redimensionamento de campos de sequências do SONHO V2 e SClínico Hospitalar.

Hospital do Espírito Santo de Évora, E. P. E.

Concessão de Exploração da Unidade de Radioterapia.

Saúde

Alteração da portaria que estabelece o regime jurídico a que obedecem as regras de prescrição e dispensa de medicamentos e produtos de saúde e define as obrigações de informação a prestar aos utentes.
ECDC - Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update

ECDC - Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update

European Centre for Disease Prevention and ControlAlthough SARS-CoV-2 transmission remains widespread in large parts of the EU/EEA, most countries report declining trends in 14-day COVID-19 notification rates, hospital and intensive care unit...
ECDC - Countering online vaccine misinformation in the EU/EEA

ECDC - Countering online vaccine misinformation in the EU/EEA

European Centre for Disease Prevention and ControlVaccines authorised by the European Medicines Agency for use in the European Union (EU) are known to be safe and effective in preventing infectious diseases. Nonetheless, misinformation that...
JAMA - SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women

JAMA - SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women

JAMA NETWORKOn December 20, 2020, Israel initiated a national vaccination program against COVID-19. One prioritized group was health care workers, many of whom are breastfeeding women. Despite the fact that the vaccine trial did not include...
NEJM - Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

NEJM - Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

The New England Journal of MedicineThe B.1.617.2 (delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has contributed to a surge in cases in India and has...
BMJ - Covid-19 vaccines for children: hypothetical benefits to adults do not outweigh risks to children

BMJ - Covid-19 vaccines for children: hypothetical benefits to adults do not outweigh risks to children

British Medical JournalAs the majority of adults in multiple rich western countries have now received at least one dose of a covid-19 vaccine, the focus is turning to children. While there is wide recognition that children’s risk of severe...
NEJM - Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

NEJM - Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

The New England Journal of MedicineInformation is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome...
NEJM - Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

NEJM - Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

The New England Journal of MedicinePatients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment...
ECDC - Threat Assessment Brief: Implications for the EU/EEA on the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern

ECDC - Threat Assessment Brief: Implications for the EU/EEA on the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern

European Centre for Disease Prevention and ControlBased on the available evidence, the SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) is 40-60% more transmissible than the Alpha (Β.1.1.7) VOC and may be associated with higher risk of...
ECDC - Indicator framework to evaluate the public health effectiveness of digital proximity tracing solutions

ECDC - Indicator framework to evaluate the public health effectiveness of digital proximity tracing solutions

European Centre for Disease Prevention and Control

As they respond to the COVID-19 pandemic, countries worldwide have increasingly looked to digital technologies in support of public health measures for contact tracing. 

124678910Último
Categorias

Categorias

Arquivo de Notícias

Arquivo